Ixazomib induces apoptosis in multiple myeloma cells through activation of caspases and other proapoptotic proteins such as p53, PUMA and Noxa and proteins involved in the endoplasmic reticulum stress pathway [40]. Here, TP53 is linked to plasma cell myeloma.